Tekla Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs funda… Read more
Tekla Healthcare Investors (HQH) - Net Assets
Latest net assets as of September 2025: $1.09 Billion USD
Based on the latest financial reports, Tekla Healthcare Investors (HQH) has net assets worth $1.09 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.10 Billion) and total liabilities ($3.43 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.09 Billion |
| % of Total Assets | 99.69% |
| Annual Growth Rate | 7.15% |
| 5-Year Change | -5.45% |
| 10-Year Change | 12.21% |
| Growth Volatility | 42.83 |
Tekla Healthcare Investors - Net Assets Trend (1996–2025)
This chart illustrates how Tekla Healthcare Investors's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Tekla Healthcare Investors (1996–2025)
The table below shows the annual net assets of Tekla Healthcare Investors from 1996 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $1.09 Billion | +3.23% |
| 2024-09-30 | $1.06 Billion | +13.77% |
| 2023-09-30 | $931.34 Million | +1.61% |
| 2022-09-30 | $916.56 Million | -20.77% |
| 2021-09-30 | $1.16 Billion | +9.69% |
| 2020-09-30 | $1.05 Billion | +21.11% |
| 2019-09-30 | $870.85 Million | -19.50% |
| 2018-09-30 | $1.08 Billion | +2.28% |
| 2017-09-30 | $1.06 Billion | +8.50% |
| 2016-09-30 | $974.78 Million | -11.73% |
| 2015-09-30 | $1.10 Billion | +4.86% |
| 2014-09-30 | $1.05 Billion | +52.62% |
| 2013-09-30 | $690.10 Million | +35.21% |
| 2012-09-30 | $510.40 Million | +34.71% |
| 2011-09-30 | $378.90 Million | +3.75% |
| 2010-09-30 | $365.20 Million | +2.50% |
| 2009-09-30 | $356.30 Million | -11.59% |
| 2008-09-30 | $403.00 Million | -9.23% |
| 2007-09-30 | $444.00 Million | +15.29% |
| 2006-09-30 | $385.10 Million | -7.67% |
| 2005-09-30 | $417.10 Million | +12.94% |
| 2004-09-30 | $369.30 Million | +28.77% |
| 2003-09-30 | $286.80 Million | +18.51% |
| 2002-09-30 | $242.00 Million | -26.53% |
| 2001-09-30 | $329.40 Million | -32.17% |
| 2000-09-30 | $485.60 Million | +207.34% |
| 1998-09-30 | $158.00 Million | -23.93% |
| 1997-09-30 | $207.70 Million | +40.72% |
| 1996-09-30 | $147.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Tekla Healthcare Investors's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 10158580100.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $101.59 Million | 9.29% |
| Common Stock | $555.10K | 0.05% |
| Other Components | $991.69 Million | 90.66% |
| Total Equity | $1.09 Billion | 100.00% |
Tekla Healthcare Investors Competitors by Market Cap
The table below lists competitors of Tekla Healthcare Investors ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gundogdu Gida Sut Urunleri Sanayi ve Dis Ticaret Anonim Sirketi
IS:GUNDG
|
$179.40K |
|
EBRO FOODS (AZU.SG)
STU:AZU
|
$179.66K |
|
SDIC Power Holdings Co Ltd GDR - Reg S
IL:SDIC
|
$179.68K |
|
DUNDEE PRECIOUS MET
BE:DPU
|
$179.70K |
|
Qwest Corp 6 75 Notes Expiry 2057
NYSE:CTDD
|
$179.27K |
|
Goodwin PLC
LSE:GDWN
|
$179.22K |
|
TEGNA (GTT.SG)
STU:GTT
|
$179.11K |
|
Inti Bangun Sejahtera Tbk
JK:IBST
|
$178.96K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tekla Healthcare Investors's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,059,595,951 to 1,093,828,807, a change of 34,232,856 (3.2%).
- Net income of 98,613,281 contributed positively to equity growth.
- Other factors decreased equity by 64,380,425.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $98.61 Million | +9.02% |
| Other Changes | $-64.38 Million | -5.89% |
| Total Change | $- | 3.23% |
Book Value vs Market Value Analysis
This analysis compares Tekla Healthcare Investors's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.93x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.73x to 0.93x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-09-30 | $25.19 | $18.36 | x |
| 1997-09-30 | $22.60 | $18.36 | x |
| 1998-09-30 | $16.34 | $18.36 | x |
| 2000-09-30 | $45.13 | $18.36 | x |
| 2001-09-30 | $26.76 | $18.36 | x |
| 2002-09-30 | $17.77 | $18.36 | x |
| 2003-09-30 | $19.20 | $18.36 | x |
| 2004-09-30 | $17.72 | $18.36 | x |
| 2005-09-30 | $19.22 | $18.36 | x |
| 2006-09-30 | $16.93 | $18.36 | x |
| 2007-09-30 | $19.14 | $18.36 | x |
| 2008-09-30 | $17.08 | $18.36 | x |
| 2009-09-30 | $14.06 | $18.36 | x |
| 2010-09-30 | $14.47 | $18.36 | x |
| 2011-09-30 | $14.46 | $18.36 | x |
| 2012-09-30 | $19.20 | $18.36 | x |
| 2013-09-30 | $24.90 | $18.36 | x |
| 2014-09-30 | $29.40 | $18.36 | x |
| 2015-09-30 | $29.61 | $18.36 | x |
| 2016-09-30 | $24.99 | $18.36 | x |
| 2017-09-30 | $26.02 | $18.36 | x |
| 2018-09-30 | $25.62 | $18.36 | x |
| 2019-09-30 | $20.33 | $18.36 | x |
| 2020-09-30 | $24.04 | $18.36 | x |
| 2021-09-30 | $25.47 | $18.36 | x |
| 2022-09-30 | $19.36 | $18.36 | x |
| 2023-09-30 | $18.84 | $18.36 | x |
| 2024-09-30 | $20.33 | $18.36 | x |
| 2025-09-30 | $19.70 | $18.36 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tekla Healthcare Investors utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.02%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 98.80%
- • Asset Turnover: 0.09x
- • Equity Multiplier: 1.00x
- Recent ROE (9.02%) is above the historical average (5.95%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | 20.30% | 11988.00% | 0.00x | 1.00x | $15.21 Million |
| 1997 | 15.97% | 4877.94% | 0.00x | 1.00x | $12.40 Million |
| 1998 | -29.87% | -7375.00% | 0.00x | 1.00x | $-63.00 Million |
| 2000 | 59.02% | 13779.33% | 0.00x | 1.00x | $238.05 Million |
| 2001 | -42.59% | -4922.46% | 0.01x | 1.00x | $-173.23 Million |
| 2002 | -31.38% | -5062.67% | 0.01x | 1.00x | $-100.14 Million |
| 2003 | 19.02% | 5510.10% | 0.00x | 1.02x | $25.87 Million |
| 2004 | 3.62% | 1936.23% | 0.00x | 1.01x | $-23.57 Million |
| 2005 | 15.01% | 4202.68% | 0.00x | 1.00x | $20.91 Million |
| 2006 | -3.90% | -470.85% | 0.01x | 1.00x | $-53.53 Million |
| 2007 | 16.94% | 3466.82% | 0.00x | 1.00x | $30.83 Million |
| 2008 | -5.92% | -1089.04% | 0.01x | 1.01x | $-64.15 Million |
| 2009 | -10.23% | -5061.11% | 0.00x | 1.03x | $-72.07 Million |
| 2010 | 5.38% | 550.14% | 0.01x | 1.03x | $-16.88 Million |
| 2011 | 8.54% | 1730.48% | 0.00x | 1.01x | $-5.53 Million |
| 2012 | 30.93% | 3130.73% | 0.01x | 1.00x | $106.80 Million |
| 2013 | 28.99% | 10226.64% | 0.00x | 1.00x | $131.07 Million |
| 2014 | 21.08% | 10354.95% | 0.00x | 1.00x | $116.70 Million |
| 2015 | 8.71% | 2220.11% | 0.00x | 1.01x | $-14.27 Million |
| 2016 | -5.75% | -1166.73% | 0.00x | 1.04x | $-153.50 Million |
| 2017 | 11.47% | 98.56% | 0.12x | 1.01x | $15.52 Million |
| 2018 | 6.40% | 97.51% | 0.07x | 1.00x | $-38.97 Million |
| 2019 | -16.68% | 0.00% | -0.16x | 1.01x | $-232.38 Million |
| 2020 | 22.87% | 99.29% | 0.23x | 1.00x | $135.73 Million |
| 2021 | 13.41% | 98.77% | 0.13x | 1.01x | $39.49 Million |
| 2022 | -21.19% | 0.00% | -0.21x | 1.01x | $-285.89 Million |
| 2023 | 6.05% | 96.93% | 0.06x | 1.00x | $-36.80 Million |
| 2024 | 17.45% | 1717.36% | 0.01x | 1.00x | $78.99 Million |
| 2025 | 9.02% | 98.80% | 0.09x | 1.00x | $-10.77 Million |
Industry Comparison
This section compares Tekla Healthcare Investors's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $310,488,743
- Average return on equity (ROE) among peers: -23.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tekla Healthcare Investors (HQH) | $1.09 Billion | 20.30% | 0.00x | $179.34K |
| Aberdeen International Inc (AABVF) | $136.31 Million | 25.56% | 0.23x | $2.78 Million |
| Acadian Asset Management Inc (AAMI) | $-17.60 Million | 0.00% | 0.00x | $1.39 Billion |
| AllianceBernstein Holding L.P. (AB) | $402.30 Million | 32.07% | 0.95x | $3.43 Billion |
| VIVO Cannabis Inc (ABCCF) | $164.13 Million | 16.36% | 0.09x | $148.26 Million |
| Associated Capital Group Inc (AC) | $502.13 Million | 5.33% | 0.17x | $42.54 Million |
| Adrian Resources Ltd (ADLRF) | $605.01 Million | 3.35% | 0.58x | $609.82 Million |
| Abrdn Emerging Markets Equity Income Fund Inc (AEF) | $85.10 Million | -65.65% | 0.01x | $77.20K |
| AGF Management Limited (AGFMF) | $1.12 Billion | 10.14% | 3.56x | $298.43 Million |
| Agronomics Limited (AGNMF) | $100.03 Million | 1.02% | 0.02x | $57.14 Million |
| AgriFORCE Growing Systems Ltd (AGRI) | $6.11 Million | -266.31% | 0.76x | $2.71 Million |